EDITORIAL
Published on 18 Mar 2024
Editorial: Data-driven clinical biosignatures and treatment for neurodegenerative diseases, volume II
doi 10.3389/fnins.2024.1396702
- 819 views
- Frontiers in Neuroscience
- Neurodegeneration
- Research Topics
- Data-driven Clinical Biosignatures and Treatment for Neurodegenerative Diseases, Volume II
Data-driven Clinical Biosignatures and Treatment for Neurodegenerative Diseases, Volume II
4,283
Total downloads
15k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 16 Jan 2024
Speaker-turn aware diarization for speech-based cognitive assessments
doi 10.3389/fnins.2023.1351848
- 1,073 views
REVIEW
Published on 21 Nov 2023
The effect of EEG and fNIRS in the digital assessment and digital therapy of Alzheimer’s disease: a systematic review
doi 10.3389/fnins.2023.1269359
- 3,094 views
- 4 citations
ORIGINAL RESEARCH
Published on 13 Sep 2023
Sex, myelin, and clinical characteristics of Parkinson’s disease
doi 10.3389/fnins.2023.1235524
- 1,542 views
- 8 citations
ORIGINAL RESEARCH
Published on 07 Sep 2023
Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment
doi 10.3389/fnins.2023.1221401
- 3,150 views
- 7 citations
ORIGINAL RESEARCH
Published on 21 Jul 2023
Unlocking the enigma: unraveling multiple cognitive dysfunction linked to glymphatic impairment in early Alzheimer’s disease
doi 10.3389/fnins.2023.1222857
- 2,124 views
- 6 citations
Published in
Frontiers in Neuroscience
- Neurodegeneration
Impact
- 15kTopic views
- 10kArticle views
- 4,283Article downloads